Dustin Deming, MD
Enriched profileProfessor, Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin School of Medicine and Public Health · University of Wisconsin School of Medicine and Public Health
Dustin Deming is Professor, Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin School of Medicine and Public Health at University of Wisconsin School of Medicine and Public Health. OpenAlex indexes 450 publications with 12,146 citations (h-index 39); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Dustin Deming, M.D., is Professor, Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin School of Medicine and Public Health. The public record shows 450 publications with 12,146 citations (h-index 39), centered on Colorectal Cancer Treatments and Studies, Cancer Cells and Metastasis, Cancer Genomics and Diagnostics. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 14 companies, 3 NIH-funded awards (2018–2026).
- Most recent indexed publication: 2026 · Clinical cancer research
- Top research focus: Colorectal Cancer Treatments and Studies
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 87.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
Sponsor: University of Wisconsin, Madison
Industry payments
Updated 27 Aug 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202516 payments$16,122openpaymentsdata.cms.gov ↗
- Regeneron Pharmaceuticals, Inc.Program year20255 payments
- Exelixis Inc.Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
41.7%Serotonin-3 Receptor Antagonist33.8%Ondansetron Hcl100%Part D≥30 patientsProton pump inhibitor7.9%Pantoprazole Sodium100%Part D<11 patientsSensory organs
33.8%Corticosteroid33.8%Dexamethasone100%Part D≥26 patientsNervous system
24.5%Phenothiazine15.1%Prochlorperazine Maleate100%Part D<11 patientsGabapentinoids9.4%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoids
Morgridge Institute for Research, Inc.
FY2026$662,514R01CA272855 - Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoids
Morgridge Institute for Research, Inc.
FY2026$55,687R01CA272855 - Functional optical imaging for rapid, label-free predictions of treatment response and clonal evolution in patient-derived cancer organoids
Morgridge Institute for Research, Inc.
FY2025$663,363R01CA272855
Congress activity
Updated 27 Aug 2026
174 congress contributions (2012–2026) across AACR, ASCO, ASH, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract 2617: Rapid assessment of patient derived cancer organoids using label-free imaging and an automated analysis pipeline.
AACR Annual Meeting
AACR2026Co-author - Abstract 2907: Characterization of tumor microenvironment phenotypes as potential biomarkers for immune infiltration
AACR Annual Meeting
AACR2026Co-author - Abstract 2911: Versican expression and proteolysis as a biomarker for CD8+ T cell infiltration across cancer types and molecular profiles
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression.
Cancer research
Article2025 - BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer.
Molecular cancer therapeutics
Article2025
Most-cited works
by citation count (OpenAlex)- 01Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyArticle1,763 citations2021
- 02Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in OncologyArticle1,373 citations2017
- 03NCCN Guidelines Insights: Colon Cancer, Version 2.2018Article1,037 citations2018
- 04Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in OncologyArticle998 citations2018
- 05Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyArticle840 citations2022
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/dustin-deming-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/dustin-deming-0312a5161
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Dustin-A-Deming-2146173078
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/university-of-wisconsin-department-of-medicine_dr-dustin-deming-leads-new-collaboration-activity-7427381503841624064-uRCc
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
blog-ecog-acrin.org/ecog-acrin-names-university-of-wisconsins-dustin-deming-as-its-young-investigator-of-the-year
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog-ecog-acrin.org ↗ - Other
connection.asco.org/do/researcher-spotlight-conquering-colorectal-cancer-dr-dustin-deming
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connection.asco.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
University of Wisconsin School of Medicine and Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog.ecog-acrin.org ↗
- Member
Big Ten Cancer Research Consortium Gastrointestinal Clinical Trial Working Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bigtencrc.org ↗ - Clinical Co-Chair
UW Carbone Cancer Center Molecular Tumor Board
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog.ecog-acrin.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Secondary affiliations
appointments beyond the home institution- Director/Founder
UW Carbone Cancer Center Colorectal and Anal Cancer Working Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Medical Director
William S. Middleton Memorial (VA) Hospital Oncology Infusion Clinic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →connection.asco.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.